Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $87.0B |
| FY2017, ended Dec 31, 2017 | $88.5B |
| FY2018, ended Dec 31, 2018 | $73.1B |
| FY2019, ended Dec 31, 2019 | $90.3B |
| FY2020, ended Dec 31, 2020 | $70.0B |
| FY2021, ended Dec 31, 2021 | $83.4B |
| FY2022, ended Dec 31, 2022 | $66.8B |
| FY2023, ended Dec 31, 2023 | $67.4B |
| FY2024, ended Dec 31, 2024 | $74.6B |
| FY2025, ended Dec 31, 2025 | $82.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $94.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $21.3B |
| FY2017, ended Dec 31, 2017 | $21.9B |
| FY2018, ended Dec 31, 2018 | $22.6B |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | — |
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | $24.3B |
| FY2023, ended Dec 31, 2023 | $28.1B |
| FY2024, ended Dec 31, 2024 | $27.5B |
| FY2025, ended Dec 31, 2025 | $28.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $29.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.89B |
| FY2017, ended Dec 31, 2017 | $6.22B |
| FY2018, ended Dec 31, 2018 | $7.10B |
| FY2019, ended Dec 31, 2019 | $6.91B |
| FY2020, ended Dec 31, 2020 | $4.96B |
| FY2021, ended Dec 31, 2021 | $7.96B |
| FY2022, ended Dec 31, 2022 | $5.83B |
| FY2023, ended Dec 31, 2023 | $5.43B |
| FY2024, ended Dec 31, 2024 | $6.30B |
| FY2025, ended Dec 31, 2025 | $7.57B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.17B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.7B |
| FY2017, ended Dec 31, 2017 | $19.5B |
| FY2018, ended Dec 31, 2018 | $21.5B |
| FY2019, ended Dec 31, 2019 | $22.4B |
| FY2020, ended Dec 31, 2020 | $62.6B |
| FY2021, ended Dec 31, 2021 | $28.9B |
| FY2022, ended Dec 31, 2022 | $53.5B |
| FY2023, ended Dec 31, 2023 | $61.2B |
| FY2024, ended Dec 31, 2024 | $56.5B |
| FY2025, ended Dec 31, 2025 | $46.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $66.5B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $47.3B |
| FY2017, ended Dec 31, 2017 | $48.9B |
| FY2018, ended Dec 31, 2018 | $55.5B |
| FY2019, ended Dec 31, 2019 | $63.9B |
| FY2020, ended Dec 31, 2020 | $53.1B |
| FY2021, ended Dec 31, 2021 | $43.9B |
| FY2022, ended Dec 31, 2022 | $71.0B |
| FY2023, ended Dec 31, 2023 | $66.8B |
| FY2024, ended Dec 31, 2024 | $73.5B |
| FY2025, ended Dec 31, 2025 | $77.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $96.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 8.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.69B |
| FY2017, ended Dec 31, 2017 | 1.65B |
| FY2018, ended Dec 31, 2018 | 1.60B |
| FY2019, ended Dec 31, 2019 | 1.52B |
| FY2020, ended Dec 31, 2020 | 1.50B |
| FY2021, ended Dec 31, 2021 | 1.48B |
| FY2022, ended Dec 31, 2022 | 1.53B |
| FY2023, ended Dec 31, 2023 | 1.56B |
| FY2024, ended Dec 31, 2024 | 1.56B |
| FY2025, ended Dec 31, 2025 | 1.55B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.56B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.56B | $150M | $355M |
| FY2017, ended Dec 31, 2017 | $2.63B | $163M | $159M |
| FY2018, ended Dec 31, 2018 | $2.82B | $174M | $86.0M |
| FY2019, ended Dec 31, 2019 | $4.53B | $178M | $88.0M |
| FY2020, ended Dec 31, 2020 | $1.67B | $189M | $15.0M |
| FY2021, ended Dec 31, 2021 | $1.55B | $207M | $43.0M |
| FY2022, ended Dec 31, 2022 | $69.0M | $202M | $21.0M |
| FY2023, ended Dec 31, 2023 | $62.0M | $224M | $951M |
| FY2024, ended Dec 31, 2024 | $173M | $232M | $32.0M |
| FY2025, ended Dec 31, 2025 | $489M | $235M | $45.0M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $700M | — | $42.0M |
Valuation
At current price- Market Cap
- $93.1B
- P/E
- 11.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.1×
- Price / Book
- 1.4×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $29.7B
- Revenue Growth YoY
- 6.7%
- Revenue CAGR 3Y
- 5.6%
- Revenue CAGR 5Y
- —. Compound annual growth over the last 5 fiscal years
- EPS Growth YoY
- 19.9%
- Net Income Growth YoY
- 18.4%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 27.5%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 12.7%
Earnings
Trailing 12 months- Net Income
- $8.17B
- EPS (diluted)
- $5.01
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $66.5B
- Total Debt
- $96.0B
- Net Debt
- $29.5B
- Total Assets
- $726B
- Total Liabilities
- $658B
- Shareholders' Equity
- $67.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $12.5B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 3.5%
- Dividend / Share
- $2.10
- Beta (5Y)
- 1.00
Every ratio is calculated from the company’s reported figures.